Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Matthew Tong
Targeted Therapeutics for Transthyretin Amyloid Cardiomyopathy: Time to Move Forward
Journal of Cardiac Failure
Cardiovascular Medicine
Cardiology
Related publications
Cancer Epigenetics: It Is Time to Move Forward to Therapy
Journal of Bioanalysis & Biomedicine
Estimating Population-Level Prevalence of Wild-Type and Variant Transthyretin Amyloid Cardiomyopathy
Journal of Cardiac Failure
Cardiovascular Medicine
Cardiology
Extrapolation of Data From the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) Further Highlights the Survival Benefit of Tafamidis in Transthyretin Amyloid Cardiomyopathy
Journal of Cardiac Failure
Cardiovascular Medicine
Cardiology
AG10 Inhibits Amyloidogenesis and Cellular Toxicity of the Familial Amyloid Cardiomyopathy-Associated V122I Transthyretin
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Treatment of Transthyretin (TTR) Amyloid Cardiomyopathy With an Antisense Oligonucleotide Inhibitor of TTR Synthesis
Orphanet Journal of Rare Diseases
Medicine
Genetics
Pharmacology
Targeted Therapeutics
Cell
Biochemistry
Genetics
Molecular Biology
Cardiovascular Disease and the UN Millennium Development Goals: Time to Move Forward
Nature Clinical Practice Cardiovascular Medicine
Novel Targeted Therapeutics for MEN2
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes
Amyloid Cardiomyopathy
Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
Biochemistry
Medicine
Genetics
Molecular Biology
